| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ABO Antibody Titer and Risk of Antibody‐Mediated Rejection in ABO‐Incompatible Renal Transplantation
|
Tobian, A.A.R.
|
|
|
10 |
5 |
p. 1247-1253
|
article
|
| 2 |
An Ongoing Issue Concerning Facial Transplantation
|
Strong, C.
|
|
|
10 |
5 |
p. 1115-1116
|
article
|
| 3 |
Antibody‐Mediated Rejection: Emergence of Animal Models to Answer Clinical Questions
|
Baldwin III, William M.
|
|
|
10 |
5 |
p. 1135-1142
|
article
|
| 4 |
Authors’ Response: The Riskiest Job in Medicine: Transplant Surgeons and Organ Procurement Travel
|
Englesbe, Michael J.
|
|
|
10 |
5 |
p. 1335
|
article
|
| 5 |
Better the Devil You Know: Response to Professor Ponticelli and Colleagues
|
Hidalgo, L.G.
|
|
|
10 |
5 |
p. 1333
|
article
|
| 6 |
CCR2 Regulates Monocyte Recruitment As Well As CD4+ Th1 Allorecognition After Lung Transplantation
|
Gelman, A.E.
|
|
|
10 |
5 |
p. 1189-1199
|
article
|
| 7 |
Commemorating the 10th anniversary of the launch of the AJT project
|
Halloran, Philip F.
|
|
|
10 |
5 |
p. 1111
|
article
|
| 8 |
Differential Requirement of CD27 Costimulatory Signaling for Naïve Versus Alloantig(en‐Primed Effector/Memory CD8+ T Cells
|
Yamaura, K.
|
|
|
10 |
5 |
p. 1210-1220
|
article
|
| 9 |
Distinct Mechanism of Small‐for‐Size Fatty Liver Graft Injury—Wnt4 Signaling Activates Hepatic Stellate Cells
|
Cheng, Q.
|
|
|
10 |
5 |
p. 1178-1188
|
article
|
| 10 |
Donor Intervention and Organ Preservation: Where Is the Science and What Are the Obstacles?
|
Feng, S.
|
|
|
10 |
5 |
p. 1155-1162
|
article
|
| 11 |
Editorial Board Members and Staff, 2000–present
|
|
|
|
10 |
5 |
p. 1112
|
article
|
| 12 |
Efficacy of Induction Therapy with ATG and Intravenous Immunoglobulins in Patients with Low‐Level Donor‐Specific HLA‐Antibodies
|
Bächler, K.
|
|
|
10 |
5 |
p. 1254-1262
|
article
|
| 13 |
Elective Surgical Patients as Living Organ Donors: A Clinical and Ethical Innovation
|
Testa, G.
|
|
|
10 |
5 |
p. 1331
|
article
|
| 14 |
Erratum
|
|
|
|
10 |
5 |
p. 1337
|
article
|
| 15 |
Evolving Paradigms That Determine the Fate of an Allograft
|
Bromberg, J.S.
|
|
|
10 |
5 |
p. 1143-1148
|
article
|
| 16 |
Fulminant Wilson's Disease Requiring Liver Transplantation in One Monozygotic Twin Despite Identical Genetic Mutation
|
Kegley, K.M.
|
|
|
10 |
5 |
p. 1325-1329
|
article
|
| 17 |
Hair Analysis Versus Conventional Methods of Drug Testing in Substance Abusers Seeking Organ Transplantation
|
Haller, D.L.
|
|
|
10 |
5 |
p. 1305-1311
|
article
|
| 18 |
HBV and HIV Coinfection and Liver Transplant
|
Coffin, C.S.
|
|
|
10 |
5 |
p. 1268-1275
|
article
|
| 19 |
Hepatitis E Virus‐Induced Neurological Symptoms in a Kidney‐Transplant Patient with Chronic Hepatitis
|
Kamar, N.
|
|
|
10 |
5 |
p. 1321-1324
|
article
|
| 20 |
Histidine‐Tryptophan‐Ketoglutarate for Pancreas Allograft Preservation: The Indiana University Experience
|
Fridell, J.A.
|
|
|
10 |
5 |
p. 1284-1289
|
article
|
| 21 |
Histopathology and Immunophenotype of the Spleen During Acute Antibody‐Mediated Rejection
|
Kaplan, B.
|
|
|
10 |
5 |
p. 1316-1320
|
article
|
| 22 |
Humoral Antibodies in Organ Transplantation: Angels or Demons?
|
Ponticelli, Claudio
|
|
|
10 |
5 |
p. 1332
|
article
|
| 23 |
Kidneys for Sale: Who Disapproves, and Why?
|
Leider, S.
|
|
|
10 |
5 |
p. 1221-1227
|
article
|
| 24 |
Kidneys for Sale: Whose Attitudes Matter?
|
Segev, D.L.
|
|
|
10 |
5 |
p. 1113-1114
|
article
|
| 25 |
Living Donation, are There Limits?
|
Mortier, F.
|
|
|
10 |
5 |
p. 1330
|
article
|
| 26 |
Low-Dose Rituximab for Posttransplant Recurrent Membranous Nephropathy
|
Cravedi, P.
|
|
|
10 |
5 |
p. 1336
|
article
|
| 27 |
Matrix Metalloproteinase 2 in Reduced‐Size Liver Transplantation: Beyond the Matrix
|
Padrissa‐Altés, S.
|
|
|
10 |
5 |
p. 1167-1177
|
article
|
| 28 |
Melanoma in Solid Organ Transplant Recipients
|
Zwald, F.O.
|
|
|
10 |
5 |
p. 1297-1304
|
article
|
| 29 |
Molecular Markers and Targeted Therapy of Skin Rejection in Composite Tissue Allotransplantation
|
Hautz, T.
|
|
|
10 |
5 |
p. 1200-1209
|
article
|
| 30 |
Overview of Guidelines for Establishing a Face Transplant Program: A Work in Progress
|
Siemionow, M.
|
|
|
10 |
5 |
p. 1290-1296
|
article
|
| 31 |
Phenotypic Expression of Recurrent Disease After Liver Transplantation
|
O’Grady, J.G.
|
|
|
10 |
5 |
p. 1149-1154
|
article
|
| 32 |
Recent Progress and New Perspectives in Studying T Cell Responses to Allografts
|
Valujskikh, A.
|
|
|
10 |
5 |
p. 1117-1125
|
article
|
| 33 |
Retransplantation After BK Virus Nephropathy in Prior Kidney Transplant: An OPTN Database Analysis
|
Dharnidharka, V.R.
|
|
|
10 |
5 |
p. 1312-1315
|
article
|
| 34 |
T Cell‐mediated Rejection of Kidney Transplants: A Personal Viewpoint
|
Halloran, P.F.
|
|
|
10 |
5 |
p. 1126-1134
|
article
|
| 35 |
The AJT Report: News and issues that affect organ and tissue transplantation
|
Pondrom, Sue
|
|
|
10 |
5 |
p. 1109-1110
|
article
|
| 36 |
The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular‐Cholangiocarcinoma
|
Panjala, C.
|
|
|
10 |
5 |
p. 1263-1267
|
article
|
| 37 |
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients
|
Humar, A.
|
|
|
10 |
5 |
p. 1228-1237
|
article
|
| 38 |
The Elephant in the Room: Failings of Current Clinical Endpoints in Kidney Transplantation
|
Schold, J.D.
|
|
|
10 |
5 |
p. 1163-1166
|
article
|
| 39 |
The Riskiest Job in Medicine: Transplant Surgeons and Organ Procurement Travel
|
Garcia, V.D.
|
|
|
10 |
5 |
p. 1334
|
article
|
| 40 |
Underutilization of Hepatitis C-Positive Kidneys for Hepatitis C-Positive Recipients
|
Kucirka, L.M.
|
|
|
10 |
5 |
p. 1238-1246
|
article
|
| 41 |
Vascular Stents in the Management of Portal Venous Complications in Living Donor Liver Transplantation
|
Cheng, Y.F.
|
|
|
10 |
5 |
p. 1276-1283
|
article
|
Journal description